Andrew P. Combs
Equibles does not estimate personal net worth.
Get an email with a short summary when Prelude Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get PRLD alertsAbout Andrew P. Combs
The proxy statement of Prelude Therapeutics Inc reports total compensation of $2,631,289 for Andrew P. Combs in fiscal 2021, including a base salary of $406,461. Disclosed compensation is on record for 2 fiscal years. Prelude Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Prelude Therapeutics Inc includes Krishna Vaddi (CEO and Board Member), Bryant D. Lim (CFO), Julian C. Baker (Board Member) and 3 others.
Affiliation history
-
Prelude Therapeutics Inc (PRLD)
Proxy statement
CurrentStart not stated–present
Last confirmed April 29, 2026
Company network
Leadership on record at Prelude Therapeutics Inc
- Krishna Vaddi CEO, Board Member
- Bryant D. Lim CFO
- Julian C. Baker Board Member
- Katina Dorton Board Member
- Martin Babler Board Member
- Paul Scherer, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Prelude Therapeutics Inc (PRLD) | EVP and Head of Chemistry | $406,461 | $2,631,289 |
| 2020 | Prelude Therapeutics Inc (PRLD) | EVP and Head of Chemistry | $321,538 | $2,016,063 |
Recent activity
No call appearances or filed executive changes recorded yet.